Northern Trust Corp Chroma Dex Corp. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

A detailed history of Northern Trust Corp transactions in Chroma Dex Corp. stock. As of the latest transaction made, Northern Trust Corp holds 377,703 shares of CDXC stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

377,703

Previous 107,886 250.09%

Holding current value

$2.07 Million

Previous $294,000 368.71%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.51 - $3.8 $677,240 - $1.03 Million	269,817 Added 250.09%	377,703 $1.38 Million
Q2 2024 Aug 14, 2024	BUY	$2.44 - $4.32 $18,465 - $32,693	7,568 Added 7.54%	107,886 $294,000
Q1 2024 May 14, 2024	BUY	$1.36 - $3.84 $8,478 - $23,938	6,234 Added 6.63%	100,318 $349,000
Q3 2023 Nov 13, 2023	SELL	$1.36 - $1.77 $856 - $1,115	-630 Reduced 0.67%	94,084 $137,000
Q2 2023 Aug 11, 2023	SELL	$1.31 - $1.79 $347 - $474	-265 Reduced 0.28%	94,714 $148,000
Q1 2023 May 15, 2023	BUY	$1.48 - $2.19 $6,870 - $10,165	4,642 Added 5.14%	94,979 $145,000
Q2 2022 Aug 12, 2022	SELL	$1.59 - $2.7 $538,183 - $913,896	-338,480 Reduced 78.93%	90,337 $151,000
Q1 2022 May 13, 2022	SELL	$2.02 - $3.92 $41,702 - $80,928	-20,645 Reduced 4.59%	428,817 $1.05 Million
Q4 2021 Feb 08, 2022	BUY	$3.74 - $6.7 $11,343 - $20,321	3,033 Added 0.68%	449,462 $1.68 Million
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.41 $165,407 - $284,609	-27,340 Reduced 5.77%	446,429 $2.8 Million
Q2 2021 Aug 13, 2021	BUY	$6.66 - $10.92 $197,369 - $323,614	29,635 Added 6.67%	473,769 $4.67 Million
Q1 2021 May 12, 2021	SELL	$4.59 - $18.74 $153,250 - $625,691	-33,388 Reduced 6.99%	444,134 $4.15 Million
Q4 2020 Feb 11, 2021	SELL	$3.93 - $5.5 $29,616 - $41,448	-7,536 Reduced 1.55%	477,522 $2.29 Million
Q3 2020 Nov 16, 2020	SELL	$4.01 - $5.56 $81,342 - $112,784	-20,285 Reduced 4.01%	485,058 $1.95 Million
Q2 2020 Aug 14, 2020	BUY	$3.0 - $5.52 $37,626 - $69,231	12,542 Added 2.55%	505,343 $2.32 Million
Q1 2020 May 14, 2020	BUY	$2.54 - $4.75 $71,851 - $134,368	28,288 Added 6.09%	492,801 $1.61 Million
Q4 2019 Feb 14, 2020	BUY	$2.83 - $4.61 $52,977 - $86,299	18,720 Added 4.2%	464,513 $2 Million
Q3 2019 Nov 13, 2019	BUY	$3.83 - $4.72 $110,618 - $136,323	28,882 Added 6.93%	445,793 $1.76 Million
Q2 2019 Aug 13, 2019	BUY	$3.71 - $4.83 $11,463 - $14,924	3,090 Added 0.75%	416,911 $1.94 Million
Q1 2019 May 13, 2019	BUY	$3.2 - $4.19 $7,632 - $9,993	2,385 Added 0.58%	413,821 $1.73 Million
Q4 2018 Feb 12, 2019	BUY	$2.8 - $4.22 $14,025 - $21,137	5,009 Added 1.23%	411,436 $1.41 Million
Q3 2018 Nov 14, 2018	BUY	$3.5 - $4.91 $1 Million - $1.41 Million	287,127 Added 240.68%	406,427 $1.74 Million
Q2 2018 Aug 14, 2018	BUY	$3.22 - $4.43 $204,141 - $280,853	63,398 Added 113.41%	119,300 $443,000
Q1 2018 May 09, 2018	BUY	$4.05 - $6.46 $57,902 - $92,358	14,297 Added 34.36%	55,902 $235,000
Q4 2017 Feb 14, 2018	BUY	$3.88 - $6.96 $3,686 - $6,612	950 Added 2.34%	41,605 $245,000
Q3 2017 Nov 13, 2017	BUY	$2.91 - $4.71 $118,306 - $191,485	40,655	40,655 $175,000

Others Institutions Holding CDXC

# of Institutions

Shares Held

17.2M

Call Options Held

66.7K

Put Options Held

8.2K

View Full List

About ChromaDex Corp.

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $375M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

More about CDXC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Chroma Dex Corp. Transaction History